Gemcitabine-Based Treatment in Poor Prognosis Patients with Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma – a Multicenter Polish Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine-Based Treatment in Poor Prognosis Patients with Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma – a Multicenter Polish Experience

Published:2015 Issue:5 Volume:24 Page:783-789
ISSN:1899-5276
Container-title:Advances in Clinical and Experimental Medicine
language:
Short-container-title:Adv Clin Exp Med

Author:

Rybka Justyna,Jurczak Wojciech,Giza Agnieszka,Paszkiewicz-Kozik Ewa,Kumiega Beata,Drozd-Sokołowska Joanna,Butrym Aleksandra,Kuliczkowski Kazimierz,Wróbel Tomasz

Publisher

Wroclaw Medical University

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous),Genetics (clinical),Internal Medicine,Pharmacology (medical),Reviews and References (medical)

Link

http://www.advances.umed.wroc.pl/pdf/2015/24/5/783.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant;Clinical Lymphoma Myeloma and Leukemia;2022-11

2. Gemcitabine, Dexamethasone, Cisplatin with Rituximab in Treatment Transplant- Ineligible Relapsed Non-Hodgkin B-cell Lymphoma Patients;Clinical Cancer Investigation Journal;2022

3. Combination of Gemcitabine with Cell-Penetrating Peptides: A Pharmacokinetic Approach Using In Silico Tools;Biomolecules;2019-11-04

4. Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer;Medicine;2017-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP